Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.67B
Enterprise Value6.49B
P/E Ratio-45.43
PEG Ratio0.04
Price/Sales Ratio2.6
Price/Book Ratio1.89
Enterprise/Revenue2.9
Enterprise/EBITDA24.4

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.05
Operating Margin0.01
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue3.05B
Revenue/Share1.73
Gross Profit1.44B
EBITDA351.49M
Net Income-104.37M
Diluted EPS-0.08

Balance Sheet

Total Cash188.33M
Total Cash/Share0.14
Total Debt914.28M
Total Debt/Equity0.29
Current Ratio0.99
Book Value Per Share2.35

Price History

52-Week Change-26.46
52-Week High6.25
52-Week Low4.08
Moving Average 50 Days4.56
Moving Average 200 Days4.67

Statistics

Average Volume7.05M
Shares Outstanding1.39B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.42
Last Split Factor3:1
Last Split DateOctober 20, 2015
AD